CD274 and lymphopenia: While bevacizumab has positive immunogenic effects including enhancing DC maturation (232), inhibiting Treg proliferation (233), and reduction of PD-L1 expression in certain immune cells (234), it can also lead to peripheral immunosuppression and exacerbate lymphopenia when combined with TMZ and radiation (235).